Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Biopharmaceutical Research and Development	130.27M	104.70M	73.73M
Biopharmaceutical Research and Development Growth	24.42%	42.00%	-
Total	130.27M	104.70M	73.73M
Total Growth	24.42%	42.00%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	130.27M	-	-
Chinese Mainland	-	104.70M	71.78M
Chinese Mainland Growth	-	45.87%	-
Overseas	-	-	1.96M
Total	130.27M	104.70M	73.73M
Total Growth	24.42%	42.00%	-

Source: S&P Global Market Intelligence.